Guardant Health
GH
#1589
Rank
โ‚น1.173 T
Marketcap
โ‚น9,035
Share price
-2.60%
Change (1 day)
198.69%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2025 (TTM): -โ‚น277.33

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น290.02. In 2024 the company made an earnings per share (EPS) of -โ‚น321.64 an increase over its 2023 EPS that were of -โ‚น386.69.

EPS history for Guardant Health from 2018 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น277.33-13.77%
2024-โ‚น321.64-16.82%
2023-โ‚น386.69-33.13%
2022-โ‚น578.2260%
2021-โ‚น361.3955.04%
2020-โ‚น233.10207.14%
2019-โ‚น75.89-19.81%
2018-โ‚น94.63

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Natera
NTRA
-โ‚น193.34-33.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
-โ‚น434.31 49.75%๐Ÿ‡บ๐Ÿ‡ธ USA